Literature DB >> 35427480

Beyond the marks: reader-effectors as drivers of epigenetics and chromatin engineering.

Kierra A Franklin1, Cara E Shields1, Karmella A Haynes2.   

Abstract

Chromatin is a system of proteins and DNA that regulates chromosome organization and gene expression in eukaryotes. Essential features that support these processes include biochemical marks on histones and DNA, 'writer' enzymes that generate or remove these marks and proteins that translate the marks into transcriptional regulation: reader-effectors. Here, we review recent studies that reveal how reader-effectors drive chromatin-mediated processes. Advances in proteomics and epigenomics have accelerated the discovery of chromatin marks and their correlation with gene states, outpacing our understanding of the corresponding reader-effectors. Therefore, we summarize the current state of knowledge and open questions about how reader-effectors impact cellular function and human disease and discuss how synthetic biology can deepen our knowledge of reader-effector activity.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cell developmental disease; chromatin modifications; epigenome; protein engineering; signal integration; transcriptional regulation

Mesh:

Substances:

Year:  2022        PMID: 35427480      PMCID: PMC9074927          DOI: 10.1016/j.tibs.2022.03.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   14.264


  97 in total

Review 1.  Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.

Authors:  Angelika Daser; Terence H Rabbitts
Journal:  Genes Dev       Date:  2004-05-01       Impact factor: 11.361

2.  Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolars.

Authors:  Francine M Benes; Benjamin Lim; Sivan Subburaju
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

3.  The essential role of acetyllysine binding by the YEATS domain in transcriptional regulation.

Authors:  Forest H Andrews; Erin K Shanle; Brian D Strahl; Tatiana G Kutateladze
Journal:  Transcription       Date:  2016

Review 4.  Readers of histone modifications.

Authors:  Miyong Yun; Jun Wu; Jerry L Workman; Bing Li
Journal:  Cell Res       Date:  2011-03-22       Impact factor: 25.617

5.  Engineering Epigenetic Regulation Using Synthetic Read-Write Modules.

Authors:  Minhee Park; Nikit Patel; Albert J Keung; Ahmad S Khalil
Journal:  Cell       Date:  2018-12-06       Impact factor: 41.582

6.  MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.

Authors:  Adlai R Grayson; Erica M Walsh; Michael J Cameron; Jernej Godec; Todd Ashworth; Jessica M Ambrose; Alexandra B Aserlind; Hongfang Wang; Gerard Evan; Michael J Kluk; James E Bradner; Jon C Aster; Christopher A French
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

7.  Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients.

Authors:  Eva Balada; Josep Ordi-Ros; Silvia Serrano-Acedo; Luis Martinez-Lostao; Miquel Vilardell-Tarrés
Journal:  J Leukoc Biol       Date:  2007-03-14       Impact factor: 4.962

8.  The dTAG system for immediate and target-specific protein degradation.

Authors:  Behnam Nabet; Justin M Roberts; Dennis L Buckley; Joshiawa Paulk; Shiva Dastjerdi; Annan Yang; Alan L Leggett; Michael A Erb; Matthew A Lawlor; Amanda Souza; Thomas G Scott; Sarah Vittori; Jennifer A Perry; Jun Qi; Georg E Winter; Kwok-Kin Wong; Nathanael S Gray; James E Bradner
Journal:  Nat Chem Biol       Date:  2018-03-26       Impact factor: 15.040

9.  Regulation of cancer epigenomes with a histone-binding synthetic transcription factor.

Authors:  David B Nyer; Rene M Daer; Daniel Vargas; Caroline Hom; Karmella A Haynes
Journal:  NPJ Genom Med       Date:  2017-01-09       Impact factor: 8.617

Review 10.  Heterochromatin Protein 1: A Multiplayer in Cancer Progression.

Authors:  Yu Hyun Jeon; Go Woon Kim; So Yeon Kim; Sang Ah Yi; Jung Yoo; Ji Yoon Kim; Sang Wu Lee; So Hee Kwon
Journal:  Cancers (Basel)       Date:  2022-02-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.